ImmunityBio
Healthcare & Life Sci
Company overview
ImmunityBio develops investigational immunotherapy treatments designed to activate both innate and adaptive immune responses against cancer and infectious diseases, based in San Diego, US. Its products include ANKTIVA, approved for bladder cancer, along with BCG-based immunotherapies and Natural Killer (NK) cell therapies. The company is part of the NantWorks group of companies. ImmunityBio is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- San Diego, United States